Back to products
Retatrutide product presentation
GLP-1 · Vial
V-GLP-003 · V003

Retatrutide

An investigational triple-pathway therapy being studied for appetite, fullness, and metabolic support. Availability is subject to physician review and applicable clinical requirements.

Medical review is required before prescription fulfillment.

Physician reviewed
Every prescription is individually reviewed.
Delivery included
Discreet, temperature-safe delivery.
  • Provider determines the appropriate dose
  • Medication, care, and delivery included
  • Ongoing care-team messaging included

May be considered for

  • Clinician-guided metabolic support
  • Structured weight-management programs
  • People seeking an individualized medical review

Potential support

  • Investigational support across GLP-1, GIP, and glucagon pathways
  • May support appetite and fullness regulation
  • Designed for use alongside nutrition and movement habits
  • Requires individualized physician oversight